Barclays PLC Teva Pharmaceutical Industries LTD Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Barclays PLC holds 324,747 shares of TEVA stock, worth $5.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

324,747

Previous 698,004 53.47%

Holding current value

$5.68 Million

Previous $9.85 Million 46.43%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $4.77 Million - $6.49 Million	-373,257 Reduced 53.47%	324,747 $5.28 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $3.23 Million - $4.37 Million	-303,177 Reduced 30.28%	698,004 $9.85 Million
Q4 2023 Feb 15, 2024	SELL	$8.12 - $10.63 $950,210 - $1.24 Million	-117,021 Reduced 10.47%	1,001,181 $10.5 Million
Q3 2023 Nov 07, 2023	BUY	$7.48 - $10.7 $519,874 - $743,671	69,502 Added 6.63%	1,118,202 $11.4 Million
Q2 2023 Aug 03, 2023	SELL	$7.2 - $9.47 $5.3 Million - $6.97 Million	-736,245 Reduced 41.25%	1,048,700 $7.9 Million
Q1 2023 May 04, 2023	BUY	$8.36 - $11.37 $6.54 Million - $8.89 Million	782,101 Added 77.99%	1,784,945 $15.8 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $1.02 Million - $1.22 Million	128,177 Added 14.65%	1,002,844 $9.15 Million
Q3 2022 Nov 03, 2022	BUY	$6.86 - $11.95 $1.8 Million - $3.13 Million	262,338 Added 42.84%	874,667 $7.06 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $1.6 Million - $2.26 Million	216,984 Added 54.88%	612,329 $4.6 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $5.5 Million - $7.05 Million	-750,574 Reduced 65.5%	395,345 $3.71 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $1.57 Million - $2.03 Million	-199,367 Reduced 14.82%	1,145,919 $9.18 Million
Q3 2021 Nov 09, 2021	SELL	$8.38 - $10.18 $622,072 - $755,691	-74,233 Reduced 5.23%	1,345,286 $13.1 Million
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $6.01 Million - $7.02 Million	607,253 Added 74.76%	1,419,519 $14.1 Million
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $615,281 - $762,259	-59,505 Reduced 6.83%	812,266 $9.37 Million
Q4 2020 Feb 11, 2021	BUY	$8.61 - $11.04 $897,902 - $1.15 Million	104,286 Added 13.59%	871,771 $8.41 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $363,316 - $537,979	42,394 Added 5.85%	767,485 $6.92 Million
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $5.06 Million - $8.18 Million	-623,149 Reduced 46.22%	725,091 $8.94 Million
Q1 2020 May 13, 2020	SELL	$6.69 - $13.45 $8.22 Million - $16.5 Million	-1,228,884 Reduced 47.68%	1,348,240 $12.1 Million
Q4 2019 Feb 10, 2020	BUY	$6.53 - $10.72 $9.17 Million - $15 Million	1,403,587 Added 119.6%	2,577,124 $25.3 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $2.29 Million - $3.57 Million	-371,900 Reduced 24.06%	1,173,537 $8.07 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $2.47 Million - $4.78 Million	304,293 Added 24.52%	1,545,437 $14.3 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $314,560 - $404,001	20,190 Added 1.65%	1,241,144 $19.5 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $2.23 Million - $3.64 Million	-152,778 Reduced 11.12%	1,220,954 $18.8 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $6.08 Million - $7.4 Million	288,537 Added 26.59%	1,373,732 $29.6 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $3.12 Million - $4.6 Million	-186,006 Reduced 14.63%	1,085,195 $26.4 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $20.9 Million - $27.7 Million	-1,255,294 Reduced 49.69%	1,271,201 $21.7 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $11.5 Million - $19.6 Million	1,028,094 Added 68.61%	2,526,495 $47.9 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $23.1 Million - $48.2 Million	1,498,401	1,498,401 $26.4 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account